Life Technologies Acquires Lung Cancer Test Developer Pinpoint Genomics
July 25, 2012
Life Technologies Acquires Lung Cancer Test Developer Pinpoint Genomics
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- FDA OK of Life Tech, Quidel C. Diff Assay Sets Stage for Future Cleared Tests on QuantStudio Dx
March 21, 2013 / PCR Insider - Life Tech Continues to Gather Evidence Backing NSCLC Dx Pervenio, As Commercialization Progresses
February 6, 2013 / Pharmacogenomics Reporter - Insight Genetics Wins $1.5M Grant to Begin Clinical Testing for ALK Mutation CDx on Qiagen Platform
October 11, 2012 / PCR Insider - Dx Focus: Life Tech Pervenio Lung RS; BD Max CRE Test; Gynecor Offers Roche Cobas HPV Test
September 27, 2012 / PCR Insider - Life Tech to Market Dx Version of QuantStudio Platform; Developing Assays with Quidel
July 26, 2012 / PCR Insider